First Page | Document Content | |
---|---|---|
Date: 2010-12-21 11:17:55 | Washington University in St. Louis Institutional Biological & Chemical Safety Committee Policy on Severe Adverse Event Reporting for Human Gene Therapy Trials As outlined in Section IV-B-2-b-(1) of the NIH Guidelines forAdd to Reading ListSource URL: ehs.wustl.eduDownload Document from Source WebsiteFile Size: 60,77 KBShare Document on Facebook |